3.87
price down icon2.76%   -0.11
 
loading
Lantern Pharma Inc stock is traded at $3.87, with a volume of 77,455. It is down -2.76% in the last 24 hours and down -14.76% over the past month. Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
See More
Previous Close:
$3.98
Open:
$3.9
24h Volume:
77,455
Relative Volume:
0.50
Market Cap:
$42.12M
Revenue:
-
Net Income/Loss:
$-19.25M
P/E Ratio:
-2.1742
EPS:
-1.78
Net Cash Flow:
$-17.87M
1W Performance:
-0.51%
1M Performance:
-14.76%
6M Performance:
+10.89%
1Y Performance:
+10.89%
1-Day Range:
Value
$3.75
$3.95
1-Week Range:
Value
$3.70
$4.28
52-Week Range:
Value
$2.55
$6.118

Lantern Pharma Inc Stock (LTRN) Company Profile

Name
Name
Lantern Pharma Inc
Name
Phone
972-277-1136
Name
Address
1920 MCKINNEY AVENUE, DALLAS, TX
Name
Employee
24
Name
Twitter
@lanternpharma
Name
Next Earnings Date
2025-08-08
Name
Latest SEC Filings
Name
LTRN's Discussions on Twitter

Compare LTRN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
LTRN
Lantern Pharma Inc
3.90 42.98M 0 -19.25M -17.87M -1.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
420.58 108.30B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
653.07 69.37B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
480.83 62.38B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
832.20 51.50B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.06 34.94B 398.11M -1.03B -868.57M -5.7032

Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-07-21 Initiated H.C. Wainwright Buy

Lantern Pharma Inc Stock (LTRN) Latest News

pulisher
01:09 AM

How Lantern Pharma Inc. stock reacts to oil pricesWeekly Loss Report & Safe Capital Growth Tips - newser.com

01:09 AM
pulisher
12:33 PM

Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers. - BioSpace

12:33 PM
pulisher
Oct 28, 2025

Lantern Pharma (NASDAQ: LTRN) Reports Complete Metabolic Response in Phase 1 LP-284 Trial at LL&M Congress - Digital Journal

Oct 28, 2025
pulisher
Oct 28, 2025

Will Lantern Pharma Inc. stock recover after recent dropWeekly Risk Report & Growth-Oriented Investment Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Using economic indicators to assess Lantern Pharma Inc. potentialIPO Watch & Target Return Focused Picks - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Lantern Pharma (LTRN) Reports Promising Phase 1 Trial Results for LP-284 - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Lantern Pharma presents LP-284 clinical data at 25th LL&M Congress - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Is Lantern Pharma Inc. stock attractive for income investorsInsider Selling & Weekly Return Optimization Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

What technical signals suggest for Lantern Pharma Inc. stockGDP Growth & Growth Focused Stock Pick Reports - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Is Lantern Pharma Inc. stock a buy before product launchesTrade Volume Summary & Advanced Technical Analysis Signals - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Lantern Pharma Inc. stock trendline breakdown2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Lantern Pharma Inc. stock maintain dividend yieldQuarterly Trade Summary & Real-Time Sentiment Analysis - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Why Lantern Pharma Inc. stock is favored by pension fundsTrade Exit Summary & Low Risk Profit Maximizing Plans - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Lantern Pharma’s Promising Phase II Lung Cancer Study: Key Insights for Investors - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Lantern Pharma’s LP-284 Study: A Potential Game-Changer in Cancer Treatment? - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Lantern Pharma’s LP-184 Study: A Potential Game-Changer in Cancer Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

When is the best time to exit Lantern Pharma Inc.July 2025 Price Swings & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025 - BioSpace

Oct 27, 2025
pulisher
Oct 26, 2025

How to interpret RSI for Lantern Pharma Inc. stock2025 Macro Impact & AI Forecasted Stock Moves - newser.com

Oct 26, 2025

Lantern Pharma Inc Stock (LTRN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Lantern Pharma Inc Stock (LTRN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Kreis Leslie W.
10% Owner
Jun 13 '25
Sale
3.09
40,000
123,600
49,957
Fletcher Aaron G.L.
10% Owner
Jun 12 '25
Sale
3.38
60,647
204,987
51,860
Fletcher Aaron G.L.
10% Owner
Jun 11 '25
Sale
3.40
950
3,230
54,746
Fletcher Aaron G.L.
10% Owner
Jun 10 '25
Sale
3.40
16
54
54,791
Kreis Leslie W.
10% Owner
Jun 12 '25
Sale
3.38
60,647
204,987
51,860
Kreis Leslie W.
10% Owner
Jun 11 '25
Sale
3.40
950
3,230
54,746
Kreis Leslie W.
10% Owner
Jun 10 '25
Sale
3.40
16
54
54,791
Fletcher Aaron G.L.
10% Owner
May 27 '25
Sale
3.05
21,037
64,163
56,467
Fletcher Aaron G.L.
10% Owner
May 29 '25
Sale
3.03
20,200
61,206
54,792
Fletcher Aaron G.L.
10% Owner
May 28 '25
Sale
2.87
15,000
43,050
55,753
$36.79
price up icon 1.06%
$90.28
price down icon 1.42%
$29.06
price down icon 0.31%
$105.25
price up icon 0.19%
biotechnology ONC
$314.80
price down icon 1.15%
$165.50
price up icon 0.04%
Cap:     |  Volume (24h):